ABM-1381

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameABM-1381
Drug Alias NameABM-1381
ClassificationOther
Mechanisms of ActionReceptor protein-tyrosine kinase erbB-2 antagonists
TargetsReceptor protein-tyrosine kinase erbB-2
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBichen (Shanghai) Pharmaceutical Technology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBichen (Shanghai) Pharmaceutical Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A